Antibiotic Resistance

BL-DetecTool

Optimisation and validation of a rapid, simple test for detecting bacteria resistant to beta-lactam antibiotics

Duration
01/01/2018 - 31/12/2018
Coordinator
Centre aux Energies Atomiques (CEA), France
Funded by
EIT Health (Innovation by Ideas)

The increasing rates of infections caused by broad-spectrum β-lactamases (ESBLs and carbapenemases)-producing  Enterobacteriaceae is a major public health concern.

To fight efficiently against the emergence and the spread of these multidrug (sometimes even pandrug) resistant bacteria, rapid detection and characterization is a prerequisite to implement proper hygiene and infection control measures, as well as a more adequate empirical treatment. Several methods already exist to detect antimicrobial resistance but these techniques require isolated bacteria and procedures with non-compatible delays (≥16 hours).

Thus, sensitive, rapid, low cost and user-friendly tests need to be implemented in clinical microbiology laboratories. Due to its characteristics the lateral flow immunoassay (LFIA) matches perfectly with these specifications.

Project objetives

The aim of this project is to validate a diagnostic tool using the LFIA technology for the detection of broad spectrum β-lactamases (CTXM) and  carbapenemases (OXA; NDM; KPC, VIM, IMP) directy from biological samples.

We will develop a test consisting of a nitrocellulose strip, which allows the immunological detection, enclosed in a plastic device, which carries out sample treatment. The devices, produced by 3D printing, will be optimized and validated with real clinical samples.

The operational procedures will be improved to fit with clinical habits and analytical specifications (specificity, reproducibility and sensitivity) and a cost-effectiveness analysis will be carried out.

At the end of this project a business concept will be established and training tools for
end-users will be available to accelerate the industrial transfer of this technology and
its implementation in care facilities.

Total funding

500,000 €

Our Team

ISGlobal staff

  • alt text
    Jordi Vila Director of the Antimicrobial Resistance Initiative and head of the Viral and Bacterial Infections Programme
  • alt text
    Clara Ballesté Coordinator of Antibiotic Resistance Inititative and Jordi Vila Project Assistant

Other projects

See Past Projects

COMBACTE

Combating Bacterial Resistance In Europe

ZIKA-Preg

Surveillance of Zika virus infection in pregnant women travelling from affected areas

VINCI

Optimizing provider-initiated HIV testing, linkage, and retention in care in the district of Manhiça, Mozambique